Home » ANIKA ENDS DEVELOPMENT PACT WITH ORTHO-MCNEIL
ANIKA ENDS DEVELOPMENT PACT WITH ORTHO-MCNEIL
Anika Therapeutics Inc. has terminated a development and commercialization contract with a pharmaceutical company for one of its products. Woburn, Mass.-based Anika (NASDAQ: ANIK) said it ended an agreement with a division of New Jersey's Ortho-McNeil Pharmaceuticals to develop and commercialize Anika's hyaluronic acid-based cosmetic tissue treatment. Hyaluronic acid is a naturally occurring substance found in the body.
Boston Business Journal (http://boston.bizjournals.com/boston/stories/2005/08/29/daily51.html/)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May